| | 恒生新经济ETF | | | 513320 | | | --- | --- | --- | --- | --- | --- | | | 跟踪恒生港股通新经济指数 | | | | | | | 该指数由港股通范围内、属于 "新经济"行业中市值最大的 | 交目 该指数涨跌 | 该指数 滚动市盈率 | 该指数自2018年 以来估值分位 | | | | 50只股票组成,主要包括信息 | | | | | | | 技术、可选消费、医疗保健行 | -1.6% | 26. 8倍 | 65. 4% | 415 | | | 恒生科技ETF易方达 | | | 513010 | | | | 跟踪恒生科技指数 | | | | | | | 该指数由港股上市公司中与科 | 令日 | 该指数 | 该指数自2020年 | | | | 技主题高度相关的、市值最大 | 该指数涨跌 | 滚动市盈率 | 发布以来估值分位 | | | | 的30只股票组成,信息技术及 | | | | | | | 可选消费行业合计占比超90% | -0. 7% | 24.6倍 | 36. 7% | | | | 港股通矢药ETF ( | | | 513200 | | ...

Group 1 - Hong Kong stocks strengthened today, with technology-related concepts such as semiconductors, integrated circuits, and chips leading the gains [1] - As of the market close, the CSI Hong Kong Stock Connect Internet Index rose by 2.3%, the Hang Seng Technology Index increased by 2.1%, and the Hang Seng Hong Kong Stock Connect New Economy Index climbed by 1.9% [1] - The CSI Hong Kong Stock Connect Medical and Health Comprehensive Index and the CSI Hong Kong Stock Connect Consumer Theme Index both rose by 1.8% [1] Group 2 - According to Wind data, as of last Friday, the net inflow for the E Fund Hang Seng Technology ETF (513010) exceeded 4 billion yuan in the past month, ranking first among similar ETFs [1] - The Hang Seng New Economy ETF tracks the Hang Seng Hong Kong Stock Connect New Economy Index, which consists of the 50 largest stocks in "new economy" sectors within the Stock Connect range [2] - The Hang Seng Technology ETF tracks the Hang Seng Technology Index, composed of the 30 largest stocks highly related to technology, with over 90% of the index comprising information technology and consumer discretionary sectors [2] Group 3 - The Hang Seng Medical ETF tracks the CSI Hong Kong Stock Connect Medical and Health Comprehensive Index, which includes 50 highly liquid and large-cap stocks in the healthcare sector, accounting for over 90% of the index [2] - The Hang Seng Internet ETF tracks the CSI Hong Kong Stock Connect Internet Index, consisting of stocks from 30 leading internet companies, primarily in information technology and consumer discretionary sectors [2] - The Hang Seng Consumer ETF tracks the CSI Hong Kong Stock Connect Consumer Theme Index, which includes 50 large-cap consumer stocks, with nearly 60% in consumer discretionary [3]

港股医药板块早盘冲高后下挫，午前再度回暖，截至午间收盘，中证港股通医药卫生综合指数上涨 0.5%，恒生港股通创新药指数上涨0.4%，中证创新药产业指数上涨0.2%，中证生物科技主题指数上涨 0.1%，沪深300医药卫生指数接近平收。 每日经济新闻 （责任编辑：张晓波 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com | 液制品及其它人体生物科技 的公司股票组成。 | 0.1% | 63.9倍 84.4% | | --- | --- | --- | | 矢约ETF ONLY | | 512010 | | 跟踪沪深300医药卫生指数 | | | | | | .. / | | 该指数聚焦A股医药卫生行 | | | | 业龙头,由沪深300指数样 | 重逢年间收费 | 19 - 191 该指数自2007年 | | 本中属于医药卫生行业的公 | 该指数涨跌 | 新闻网 发布以来估值分位 | | 司股票组成,全面覆 ...

Core Insights - The Hang Seng Technology Index increased by 5.1% this week, while the Hang Seng New Economy Index rose by 3.6% [1] - The ChiNext Hong Kong Stock Connect Internet Index and the Consumption Theme Index saw increases of 2.8% and 1.5%, respectively, while the ChiNext Hong Kong Stock Connect Healthcare Index decreased by 2.2% [1] - The E Fund Hang Seng Technology ETF (513010) experienced a net inflow of over 500 million yuan this week, bringing its total size to over 20 billion yuan [1] - CITIC Securities indicated that after entering September, the A-share market has entered a consolidation phase with increasing volatility, while external and internal funds are showing heightened interest in Hong Kong stocks [1] Index Performance - The weekly performance of various indices is as follows: - Hang Seng Technology Index: +5.1% - Hang Seng New Economy Index: +3.6% - ChiNext Hong Kong Stock Connect Internet Index: +2.8% - ChiNext Hong Kong Stock Connect Consumption Theme Index: +1.5% - ChiNext Hong Kong Stock Connect Healthcare Index: -2.2% [3] Valuation Metrics - The rolling price-to-earnings (P/E) ratios and their respective percentiles are: - Hang Seng Technology Index: 23.8x, 34.0% percentile - ChiNext Hong Kong Stock Connect Internet Index: 25.5x, 28.9% percentile - ChiNext Hong Kong Stock Connect Consumption Theme Index: 22.3x, 25.1% percentile - ChiNext Hong Kong Stock Connect Healthcare Index: 31.8x, 49.1% percentile [3][5] Historical Performance - Year-to-date performance for various indices shows significant growth: - Hang Seng New Economy Index: +48.3% - Hang Seng Technology Index: +40.9% - ChiNext Hong Kong Stock Connect Healthcare Index: +94.9% - ChiNext Hong Kong Stock Connect Internet Index: +54.1% - ChiNext Hong Kong Stock Connect Consumption Theme Index: +33.0% [8]

Group 1 - The Hang Seng Technology Index rose by 4.2%, the CSI Hong Kong Stock Connect Internet Index increased by 3.9%, the Hang Seng Hong Kong Stock Connect New Economy Index went up by 3.3%, the CSI Hong Kong Stock Connect Consumer Theme Index climbed by 2.1%, and the CSI Hong Kong Stock Connect Medical and Health Comprehensive Index saw a slight increase of 0.1% [1] - According to Galaxy Securities, under the expectation of a Federal Reserve interest rate cut, foreign capital is showing a structural preference for the Chinese Hong Kong stock market, primarily focusing on technology, finance, and certain consumer and manufacturing sectors, with a particular emphasis on technology stocks, healthcare, and biotechnology [1] Group 2 - The Hang Seng New Economy Index consists of 50 stocks from the "new economy" sector within the Hong Kong Stock Connect, primarily including information technology, consumer discretionary, and healthcare industries [2] - The index has a rolling price-to-earnings ratio of 25.5 times and has seen a valuation percentile increase of 59.2% since its inception in 2018 [2] - The Hang Seng Technology Index is composed of 30 stocks highly related to technology, with over 90% of its weight in information technology and consumer discretionary sectors, and it has a rolling price-to-earnings ratio of 23.4 times, with a valuation percentile increase of 32.3% since its launch in 2020 [2] - The CSI Hong Kong Stock Connect Medical and Health Comprehensive Index includes 50 liquid and large-cap stocks in the healthcare sector, which accounts for over 90% of the index's weight, with a rolling price-to-earnings ratio of 31.6 times and a valuation percentile increase of 48.9% since its inception in 2017 [2] - The CSI Hong Kong Stock Connect Internet Index consists of 30 leading internet companies, primarily in information technology and consumer discretionary sectors, with a rolling price-to-earnings ratio of 25.2 times and a valuation percentile increase of 27.4% since its launch in 2021 [2]

Group 1 - The Hang Seng Hong Kong Stock Connect Innovative Drug Index decreased by 0.4%, while the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index fell by 0.1% [1] - The CSI Biotechnology Theme Index increased by 0.1%, and the CSI Innovative Drug Industry Index rose by 0.2% [1] - The CSI 300 Pharmaceutical and Health Index saw an increase of 0.4% [1] Group 2 - The Hang Seng Innovative Drug ETF (159316) experienced a net inflow of 580 million yuan last week, bringing its total size to 2.7 billion yuan, marking a historical high [1] - The rolling price-to-earnings ratio for the pharmaceutical and health industry is reported at 33.5 times, with a valuation percentile of 63.4% [4] - The liquid products and other human biotechnology sector have a rolling price-to-earnings ratio of 64.2 times, with a valuation percentile of 85.3% [4]

Core Insights - The Hong Kong stock market showed mixed performance this week, with technology stocks leading gains while pharmaceutical stocks experienced a correction. Southbound capital net purchases exceeded 60 billion HKD [1] - The CSI Hong Kong Stock Connect Internet Index rose by 5.7%, the Hang Seng Technology Index increased by 5.3%, while the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index fell by 1.7% [1][3] - The Hang Seng Technology ETF (513010) has seen net inflows for 12 consecutive trading days, totaling over 2.5 billion HKD, with the latest product size reaching 18.2 billion HKD, setting new historical highs [1] Index Performance - The weekly performance of various indices includes: - CSI Hong Kong Stock Connect New Economy Index: +3.4% - Hang Seng Technology Index: +5.3% - CSI Hong Kong Stock Connect Internet Index: +5.7% - CSI Hong Kong Stock Connect Consumption Theme Index: +3.4% - CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index: -1.7% [3][5] - The rolling price-to-earnings (P/E) ratios for these indices are as follows: - CSI Hong Kong Stock Connect New Economy Index: 24.7x - Hang Seng Technology Index: 22.7x - CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index: 31.1x - CSI Hong Kong Stock Connect Internet Index: 24.5x - CSI Hong Kong Stock Connect Consumption Theme Index: 21.6x [3][5] Historical Performance - The cumulative performance over different time frames is as follows: - 1-month: Hang Seng Technology Index +6.4%, CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index +6.2% - 3-month: Hang Seng Technology Index +14.3%, CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index +28.0% - Year-to-date: Hang Seng Technology Index +34.0%, CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index +99.4% - 1-year: Hang Seng Technology Index +72.1%, CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index +109.1% - 3-year: Hang Seng Technology Index +47.2%, CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index +45.8% - 5-year: CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index -16.6% [7][8]

Market Overview - The Hong Kong stock market showed mixed performance today, with financial and real estate sectors continuing to rise, while pharmaceutical and new consumption sectors experienced widespread declines [1] - The Hang Seng Technology Index increased by 1.3%, the CSI Hong Kong Stock Connect Internet Index rose by 1.1%, the Hang Seng Stock Connect New Economy Index gained 0.2%, and the CSI Hong Kong Stock Connect Consumer Theme Index saw a slight increase of 0.1%. In contrast, the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index fell by 1.1% [1] ETF Performance - The E Fund Hang Seng Technology ETF (513010) has recorded net inflows for 10 consecutive trading days, totaling over 2 billion yuan, with the latest scale reaching 17.6 billion yuan, marking a historical high [1] - The Hang Seng New Economy ETF (513320) tracks the Hang Seng Stock Connect New Economy Index, which consists of 50 stocks from the "new economy" sector with the largest market capitalization [2] - The Hang Seng Technology ETF (513010) tracks the Hang Seng Technology Index, composed of 30 stocks highly related to technology themes, with over 90% of the index comprising information technology and consumer discretionary sectors [2] - The CSI Hong Kong Stock Connect Pharmaceutical ETF (513200) tracks the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index, which includes 50 liquid and large-cap stocks in the healthcare sector [2] - The CSI Hong Kong Stock Connect Internet ETF (513040) tracks the CSI Hong Kong Stock Connect Internet Index, consisting of 30 leading internet companies, primarily in information technology and consumer discretionary sectors [2] Valuation Metrics - The rolling P/E ratio for the Hang Seng New Economy Index is 24.8 times, with a valuation percentile of 55.4% since 2018 [2] - The rolling P/E ratio for the Hang Seng Technology Index is 22.5 times, with a valuation percentile of 27.4% since its inception in 2020 [2] - The rolling P/E ratio for the CSI Hong Kong Stock Connect Pharmaceutical Index is 32.3 times, with a valuation percentile of 50.2% since 2017 [2] - The rolling P/E ratio for the CSI Hong Kong Stock Connect Internet Index is 24.4 times, with a valuation percentile of 24.4% since its inception in 2021 [2] - The rolling P/E ratio for the E Fund Hong Kong Consumption ETF (513070) is 21.7 times, with a valuation percentile of 21.9% since its inception in 2020 [3]

Core Insights - The Hang Seng Hong Kong Stock Connect Innovation Drug Index increased by 7.1% this week, while the CSI Hong Kong Stock Connect Medical and Health Comprehensive Index rose by 6.9% [1] - The CSI Innovation Drug Industry Index and the CSI Biotechnology Theme Index saw increases of 5.3% and 3.6%, respectively, with the CSI 300 Medical and Health Index up by 3.4% [1] - The Hang Seng Innovation Drug ETF (159316) experienced a net inflow of nearly 200 million yuan this week, bringing its total size to over 2 billion yuan, a record high [1] Index Performance - Weekly performance: - Hang Seng Innovation Drug Index: +7.1% - CSI Hong Kong Stock Connect Medical and Health Comprehensive Index: +6.9% - CSI Innovation Drug Industry Index: +5.3% - CSI Biotechnology Theme Index: +3.6% - CSI 300 Medical and Health Index: +3.4% [3] - Year-to-date performance: - Hang Seng Innovation Drug Index: +116.2% - CSI Hong Kong Stock Connect Medical and Health Comprehensive Index: +102.9% - CSI Innovation Drug Industry Index: +43.5% - CSI Biotechnology Theme Index: +31.2% - CSI 300 Medical and Health Index: +22.9% [7] Valuation Metrics - Current rolling P/E ratios: - Hang Seng Innovation Drug Index: 57.7x - CSI Hong Kong Stock Connect Medical and Health Comprehensive Index: 30.7x - CSI Innovation Drug Industry Index: 57.3x - CSI Biotechnology Theme Index: 62.3x - CSI 300 Medical and Health Index: 33.0x [3] - Valuation percentile as of July 2023: - Hang Seng Innovation Drug Index: 48.5% - CSI Hong Kong Stock Connect Medical and Health Comprehensive Index: 88.1% - CSI Innovation Drug Industry Index: 82.1% - CSI Biotechnology Theme Index: 60.2% [3] ETF Overview - The Hang Seng Innovation Drug Index has one ETF tracking it, while the CSI Hong Kong Stock Connect Medical and Health Comprehensive Index has four ETFs [5] - The CSI Innovation Drug Industry Index is tracked by seven ETFs, and the CSI Biotechnology Theme Index has four ETFs [5]

Core Insights - The Hang Seng Hong Kong Stock Connect Innovative Drug Index increased by 3.7%, while the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index rose by 2.7% [1] - The CSI Innovative Drug Industry Index and the CSI Biotechnology Theme Index both saw a 2.0% increase, and the CSI 300 Pharmaceutical and Health Index rose by 1.8% [1] - The Hang Seng Innovative Drug ETF (159316) experienced a net subscription of 6 million units in half a day, with a net inflow exceeding 1 billion yuan in the past month, bringing its total scale to over 2 billion yuan, a record high [1] Index Performance - The CSI Innovative Drug Industry Index consists of no more than 50 stocks primarily involved in innovative drug research and development, representing the leading companies in A-share innovative drugs [5] - The index has a rolling price-to-earnings ratio of 57.3 times and has appreciated by 88.1% since its inception [6] - The CSI Biotechnology Theme Index, which focuses on leading A-share biotechnology companies, also consists of no more than 50 stocks involved in gene diagnosis, biopharmaceuticals, and other human biotechnology sectors, with a rolling price-to-earnings ratio of 62.3 times and an appreciation of 82.1% since its inception [7] Sector Coverage - The CSI 300 Pharmaceutical and Health Index covers leading companies in the pharmaceutical and health industry, including segments such as chemical pharmaceuticals, medical services, and medical devices [8] - This index has a rolling price-to-earnings ratio of 33.0 times and has appreciated by 60.2% since its inception [9]